Four 40 kg wethers were used in a crossover design to quantify, by arterio -venous procedures, the mass transfer of NH 3 , urea and amino acids (AAs) across the portal-drained viscera and the liver during a 31 min infusion of either 0 (C0) or 1100 (C1100) mmol NH 4 HCO 3 /min into the mesenteric vein. In C1100, hepatic NH 3 extraction remained stable at 1214 mmol/min (1 : 90 mmol/min per g wet liver weight), the capacity for hepatic NH 3 removal was exceeded by 654 mmol/min ðP , 0 : 05Þ and the incremental (C1100-C0) urea-N release: NH 3 -N removal ratio increased progressively, from 0 : 52 to 0 : 90. The NH 4 HCO 3 infusion reduced total branchedchain AA ðP , 0 : 05Þ transfer across the portal-drained viscera and total AA-N ðP ¼ 0 : 09Þ and lysine ðP ¼ 0 : 02Þ extraction by the liver. Hepatic release of glutamate was augmented ðP ¼ 0 : 03Þ; ornithine switched from net release to net removal ðP , 0 : 001Þ and net splanchnic release of free essential AA (44 mmol/min (SED 9 : 2), P ¼ 0 : 04) and branched-chain AA (33 mmol/min (SED 2 : 0), P ¼ 0 : 001) were reduced to 0 : 58 of their basal rate. The study showed that conversion of excess NH 3 to urea during a short-term hepatic NH 3 overload required no additional contribution of AA-N to ureagenesis; essential AA and branched-chain AA supply to non-splanchnic tissues was, however, temporarily decreased.
Large quantities of NH 3 are formed in the gastrointestinal tract of ruminant animals from the degradation of dietary nitrogenous compounds and the microbial hydrolysis of endogenous urea. Once absorbed across the gut wall, the NH 3 is completely removed from the splanchnic circulation by the liver (Nieto et al. 1996) and used for urea and, to a lesser extent, amino acid (AA) synthesis (e.g. glutamate, aspartate and glutamine; Lobley et al. 1996) .
The role of hepatic ureagenesis in N metabolism is twofold: prevention of portal NH 3 from reaching the peripheral circulation and disposal of the AA-N excess to body requirements. Urea synthesis requires balanced N inputs from citrulline and aspartate. Citrulline-N originates from mitochondrial NH 3 in a reaction catalysed, sequentially, by carbamoyl-phosphate synthase 1 and ornithine transcarbamylase. The aspartate-N, supplied primarily through transamination with glutamate, arises mainly from two sources: (1) the 2-amino-N of transaminating AAs; or (2) direct synthesis of glutamate from mitochondrial NH 3 and 2-oxoglutarate, via the reaction controlled by glutamate dehydrogenase (Stryer, 1988) . NH 3 -N can, therefore, provide both N atoms of urea, as demonstrated in cultures of sheep hepatocytes incubated with 15 NH 4 Cl where, regardless of the presence of AA in the incubation medium, [ 15 N 15 N]urea was the predominant labelled species synthesised Luo et al. 1995) . Thus, hepatic detoxification of absorbed NH 3 , which can account for up to 0 : 5-0 : 65 of dietary N intake (Parker et al. 1995) , may not need an obligate equimolar N input from AA (Reynolds, 1992; Parker et al. 1995 ).
This view is not supported by results from short-term (2 -3 h), trans-hepatic experiments in vivo, where the urea-N released by the liver greatly exceeded the additional NH 3 supplied to the liver (Symonds et al. 1981; Barej et al. 1987; Orzechowsky et al. 1988; Wilton et al. 1988 ). If transient, high inputs of NH 3 stimulate AA utilisation for ureagenesis, daily access to feedstuffs with high concentrations of non-protein-N or rapidly degradable protein-N for short periods may reduce AA availability for protein anabolism.
In the current experiment, the hypothesis that a large, short-term increase in portal NH 3 flow augments AA utilisation for urea synthesis was tested by increasing the supply of NH 3 beyond the maximum capacity for hepatic NH 3 by infusion of 1100 mmol NH 4 HCO 3 /min into the mesenteric vein of fed sheep.
Materials and methods

Animals
Four Suffolk cross-bred male lambs (35 -40 kg body weight), surgically prepared with indwelling silicone rubber catheters in the posterior aorta, portal, hepatic and mesenteric veins , were placed in metabolism crates under continuous lighting conditions. The sheep were adjusted to receiving 770 g DM (grass pellets)/d (10 MJ metabolizable energy/kg DM, 22 g N/kg DM) in hourly portions throughout the experiment and for at least 10 d before the first experimental period, using automated feeders. Water was freely available.
Design
The experiment was arranged as a non-randomised, crossover design with two experimental periods, each of 161 min, separated by a 5-7 d interval. Throughout each experimental period, the sheep were infused via the mesenteric vein with a solution containing 0 : 1 M sodium p-amino hippuric acid (Sigma, St Louis, MO, USA), 0 : 05 M-sodium phosphate buffer (pH 7 : 4) and 400 IU heparin/g (Heparin (Mucous); Leo Laboratories Ltd, Princes Risborough, Bucks., UK), at a rate of 20 g/h. Between 60 and 130 min of each experimental period, the sheep were infused with physiological saline (152 mM-NaCl, 167 : 2 mmol NaCl/min) via the mesenteric vein. From 130 min to the end of each experimental period, the infusion of physiological saline via the mesenteric vein was either maintained (C0) or replaced by a 1 M-NH 4 HCO 3 , 152 mM-NaCl solution (C1100; 1100 mmol NH 4 HCO 3 /min plus 167 : 2 mmol NaCl/min). Two sheep followed the sequence C0 -C1100 while the other two sheep followed the reverse sequence. All solutions were sterilised by autoclave or filtration, as appropriate, and infusions were performed with peristaltic pumps.
Samples
Three simultaneous blood samples were continuously collected from the aorta, portal and hepatic veins at 7 min intervals (0 : 3 ml/min per catheter), during the last 21 min of each experimental period, using a peristaltic pump. An additional mixed blood sample (10 ml) was collected at the end of each experimental period for determination of blood and plasma DM.
Immediately following the study (2 weeks), portal catheter patency was lost in two of the sheep. This meant they could not be used for subsequent studies and were therefore killed. As they had been maintained postexperiment on the same diet and intake, the opportunity was taken to examine liver mass. This enabled the absolute measurements obtained to be expressed per unit weight. The sheep were weighed and then killed by an intravenous overdose of thiopental, followed by exsanguination. The liver was rapidly separated from other abdominal organs and surrounding connective and adipose tissue and weighed.
Analyses
Blood samples were mixed and analysed for blood pCO 2 , pH, bicarbonate and haemoglobin concentration immediately after collection using a blood gas analyser (Acid Base Laboratory Radiometer ABL3; Radiometer, Copenhagen, Denmark). The packed cell volume was determined by microhaematocrit. One portion (0 : 5 g) of blood was deproteinised with 5 g TCA (120 g/l) and processed for gravimetric determination of p-amino hippuric acid . The remainder of the blood was centrifuged at 1000 g for 10 min at 48C, the plasma (approximately 1 : 0 ml) collected and processed for determination of NH 3 , by an automated procedure (Kone Autoanalyser; Kone, Espoo, Finland) according to Mondzac et al. (1965) , and urea, by GC -mass spectrometry (Milano et al. 2000) . The three arterial, portal and hepatic vein plasma samples from each experimental period were pooled in proportion to the plasma flow (pooled sample weight, approximately 0 : 5 g), and processed for AA analysis in physiological fluids with an Alpha Plus amino acid analyser (Pharmacia-LKB Biochrom Ltd, Cambridge, UK) as described by Lobley et al. (1995) .
Calculations
Blood, plasma and whole blood water flows and NH 3 , urea and AA transfers across the portal-drained viscera (PDV) and the liver were calculated as described by Milano et al. (2000) . Hepatic NH 3 and urea-N inflow (I, mmol/min) and outflow (O, mmol/min) were calculated from:
where Fp and Fh are the blood (for NH 3 ) or whole blood water (for urea) flow in the portal vein and hepatic vein (g/ min), respectively and Ca, Cp and Ch are the concentrations of metabolites in plasma (NH 3 , nmol/g) or plasma water fraction (urea, estimated as plasma urea concentration/ (12plasma DM fraction); nmol/g) in the aorta, portal vein and hepatic vein, respectively.
Statistical analysis
The data were initially analysed by ANOVA, as a crossover design, with animals as blocks and treatment (NH 4 HCO 3 administration) and period as factors. The effect of period was significant ðP , 0 : 05Þ only for plasma urea concentration, NH 3 , urea and non-NH 3 urea-N transfers across the liver and PDV release of valine. For all other data, this factor was removed and the data re-analysed by ANOVA with animals as blocks and treatment as the sole factor. Analyses were performed using the Genstat 5 (release 3.2) statistical package (Rothamstead Experimental Station, Herts., UK).
Results
Animals, catheters and liver samples
All animals completed the experiment and the catheters remained patent (i.e. allowed both blood collection and infusion of solutions), with the exception of one arterial catheter. In this animal, an additional polyvinyl chloride catheter was placed into the right ventricle via a jugular vein and, in both experimental periods, mixed venous heart blood was used for all determinations, except blood gas analysis. Comparative analyses of arterial and mixed right ventricle blood, performed later in two other animals, showed no significant differences between sampling sites in the concentration of urea and individual or total AAs (results not shown). Under basal conditions (C0), the concentration of NH 3 in the right ventricle blood was closer to that in the hepatic vein than to that in the artery. In practice, the small contribution of the hepatic artery to the total NH 3 supply to the liver meant that the error introduced was #0 : 2 and #2 : 0 % total NH 3 supply or removal for C0 and C1100, respectively.
The fresh liver weights of the two sheep killed were 630 and 653 g, with fractional liver weights of 0 : 015 and 0 : 017 g/kg body weight, respectively.
Acid -base parameters and blood flow
Bicarbonate concentration increased in the aorta (1 : 2 mM, P ¼ 0 : 03), the hepatic (2 : 6 mM, P ¼ 0 : 004) and the portal vein (2 : 8 mM, P ¼ 0 : 03) during NH 4 HCO 3 administration while pCO 2 remain unchanged in all three sampling sites (Table 1) . A small elevation in blood pH (0 : 02 pH units, P ¼ 0 : 055) was recorded in the portal vein. The blood flows in the portal and hepatic veins were not altered by the NH 4 HCO 3 infusion and averaged 40 : 6 (SEM 3 : 6) and 48 : 4 (SEM 3 : 5) g/kg body weight per min, respectively. The hepatic artery contributed 16 % of the total liver blood flow.
Plasma urea and ammonia concentration
Average plasma NH 3 concentration increased in the portal ðP ¼ 0 : 004Þ and hepatic veins ðP ¼ 0 : 026Þ following NH 4 HCO 3 infusion (Table 1 ). In the aorta, NH 3 concentration increased progressively to 406 mM (SEM 125 mM; Fig. 1 ) by the end of the NH 4 HCO 3 infusion. This is approximately 50 % of the value associated with severe NH 3 toxicity in ruminant animals (Symonds et al. 1981) ; but the sheep showed none of the commonly reported clinical signs of NH 3 toxicity (e.g. restlessness, respiratory distress or rapid respiratory movements; Symonds et al. 1981) . Average plasma urea concentration was 1 : 0-1 : 2 mM higher ðP , 0 : 02Þ in all three sampling sites during NH 4 HCO 3 infusion.
Urea and ammonia transfers
Basal (C0) NH 3 appearance across the PDV represented 0 : 36 of the apparent total N entering the gastrointestinal tract (i.e. N intake1urea-N uptake by the PDV, 1219 mmol N/min) and 0 : 57 of the total N apparently absorbed by the gastrointestinal tract (Table 2) . This was not significantly different from urea-N removal by the PDV (435 v. 404 mmol/N min; P . 0 : 2). PDV transfer of NH 3 , but not urea, increased by 1069 mmol/min ðP , 0 : 001Þ during the NH 4 HCO 3 infusion, similar to the average infusion rate (1180 mmol N/min), indicating that the basal rate of NH 3 appearance across the PDV was not altered by the infusion. Liver inflow, outflow and removal of NH 3 were all increased by the NH 4 HCO 3 infusion. The average NH 3 input to the liver in C1100 exceeded the maximum capacity for hepatic removal of NH 3 by 654 mmol/min, so that NH 3 exited the liver at a rate 5 : 7 times higher than that measured in C0. Based on an average liver weight of 642 g, the hepatic NH 3 removal during NH 4 HCO 3 infusion was 1 : 90 mmol/ min per g wet liver weight (see Table 2 ).
Hepatic urea-N release was 1 : 9 times higher than NH 3 uptake under basal (C0) conditions and increased to 1354 mmol/min in C1100 ðP , 0 : 001Þ; sufficient to account for hepatic NH 3 removal. When the data were compared on an incremental basis (i.e. C1100 -C0), urea-N release was on average only 0 : 71 of the NH 3 removal, resulting in an apparent net decrease in the calculated non-NH 3 -N appearing as urea-N (P ¼ 0 : 004; Table 2 ). The time course of NH 3 and urea transfers during NH 4 HCO 3 infusion (Fig. 1) showed, however, that while hepatic NH 3 extraction remained unaltered for the 21 min sampling period (slope 21 : 06 mmol/min per min (SE of the slope 4 : 879), P ¼ 0 : 83; residual mean square 9333 : 14), urea-N release by the liver increased progressively from 1278 to 1474 mmol/min (slope 14 : 06 mmol/min per min (SE of the slope 7 : 22), P ¼ 0 : 07; residual mean square 20437 : 6). Thus, the additional urea-N release: additional NH 3 -N removal ratio increased from 0 : 52 to 0 : 90 over the same period.
Plasma amino acid concentrations
Arterial, portal and hepatic vein plasma concentrations of free total AA (aorta 2625 mM (SEM 99 : 5)), essential AA (aorta 986 mM (SEM 53 : 0)), non-essential AA (aorta 1351 mM (SEM 42 : 6)), branched-chain AA (aorta 566 mM (SEM 36 : 5)) and glucogenic AA (aorta 927 mM (SEM 34 : 8)) were not altered by the NH 4 HCO 3 infusion. Glutamine concentration was higher in the aorta (222 v. 308 mM (SED 18 : 6), P ¼ 0 : 02), the portal (221 v. 302 mM (SED 11 : 8), P ¼ 0 : 01Þ and the hepatic (199 v. 292 mM (SED 17 : 3), P ¼ 0 : 02) veins and a similar, though smaller, response was apparent for aspartate (aorta 7 v. 10 mM (SED 0 : 8), P , 0 : 05). In contrast, ornithine concentration was consistently decreased at all sites (aorta 102 v. 70 mM (SED 7 : 3), P ¼ 0 : 02; portal vein 108 v. 76 mM (SED 8 : 0), P ¼ 0 : 03; hepatic vein 112 v. 71 mM (SED 8 : 6), P ¼ 0 : 02) in C1100. Lower concentrations were also observed for alanine (200 v. 173 mM (SED 7 : 4), P ¼ 0 : 04), tyrosine (104 v. 98 mM (SED 2 : 0), P ¼ 0 : 05) and phenylalanine in the portal vein (86 v. 74 mM (SED 3 : 1), P ¼ 0 : 03), with similar trends for threonine in both the aorta (86 v. 74 mM (SED 3 : 1), P ¼ 0 : 08) and the portal vein (194 v. 168 mM (SED 9 : 3), P ¼ 0 : 07) and alanine in the aorta (158 v. 140 mM (SED 7 : 9), P ¼ 0 : 1).
Amino acid transfers
With the exception of glutamine, which was removed by the gastrointestinal tissues, a net absorption of all other AAs was measured across the PDV in C0, with essential AA representing 0 : 43 of total AA transfers. The net release of free total AA, non-essential AA and glucogenic AA across the PDV was not modified by NH 4 HCO 3 infusion. The reduction in net PDV release of valine ðP ¼ 0 : 018Þ and the trend for decreased net PDV release of isoleucine ðP ¼ 0 : 09Þ and leucine ðP ¼ 0 : 07Þ; resulted in significantly reduced total branched-chain AA transfers ðP ¼ 0 : 04Þ and in a trend for lower free essential AA transfers across the PDV ðP ¼ 0 : 09Þ in C1100 (see Table 3 ).
Under basal conditions, the liver removed 0 : 71, 0 : 45, 0 : 21 and all of the free total AA, essential AA, branched-chain AA and non-essential AA respectively, absorbed across the PDV. The free glucogenic AA were extracted at a rate 1 : 4 times greater than the PDV appearance, while net hepatic release was observed for glutamate and ornithine. The NH 4 HCO 3 infusion reduced total AA-N extraction by 152 mmol/min, a decrease similar to the average reduction in non-NH 3 urea-N release (222 mmol/min (SED 63), P ¼ 0 : 59; Table 2 ). Glutamate release ðP ¼ 0 : 03Þ was significantly augmented, ornithine switched from net release to net removal ðP , 0 : 001Þ and there was a reduction in lysine extraction ðP ¼ 0 : 02; Table 3 ).
Splanchnic bed release of valine (12 v. 6 mmol/min (SED 22 : 4), P ¼ 0 : 09), isoleucine (19 v. 12 mmol/min (SED 2 : 3), P ¼ 0 : 07), leucine (26 v. 14 mmol/min (SED 1 : 4), P , 0 : 01), and tyrosine (4 v. 1 mmol/min (SED 0 : 7), P ¼ 0 : 03) were reduced during NH 4 HCO 3 infusion. This meant that the net appearance of free branched-chain AA (57 v. 33 mmol/min (SED 2 : 0), P ¼ 0 : 001) and essential AA (76 v. 44 mmol/min (SED 9 : 2), P ¼ 0 : 04) across the splanchnic tissues during C1100 dropped to 0 : 58 of that under basal conditions. In addition, the splanchnic tissues released more citrulline (3 v. 14 mmol/min (SED 1 : 7), P ¼ 0 : 01) and arginine (22 v. 7 mmol/min (SED 2 : 4), P ¼ 0 : 04), but almost no ornithine (13 v. 1 mmol/min (SED 1 : 3), P , 0 : 01), to the peripheral circulation.
Discussion
Short-term adaptation of glutamate dehydrogenase activity v. amino acid degradation: how to balance citrulline synthesis in the ornithine cycle Experiments with 15 NH 4 Cl in vitro Luo et al. 1995) and in vivo (Milano et al. 1995) have offered unequivocal evidence that NH 3 -N can provide both N atoms of urea during hepatic ureagenesis in sheep. Moreover, in recent studies in sheep with chronic (4 d) infusion of NH 4 HCO 3 into the mesenteric vein, all additional NH 3 -N removed by the liver was converted into urea without the need for substantial inputs of AA-N (i.e. the additional urea-N released: additional NH 3 -N removed ratio by the liver ranged from 0 : 9 to 1 : 1; Lobley et al. 1996; Milano et al. 2000) . Overall, these observations indicate that under conditions of sustained, high portal NH 3 flows, hepatic glutamate dehydrogenase activity and related pathways that supply 2-oxoglutarate and NADH can adjust to allow partition of the extra portal NH 3 removed equally between glutamate dehydrogenase and carbamoyl-phosphate synthase 1 -ornithine transcarbamylase routes, without compromising amino acid-N to balance N inputs to the urea cycle.
In earlier studies, however, where ammonium salts were infused for 2 or 3 h into the mesenteric vein of sheep (Barej et al. 1987; Orzechowsky et al. 1988 ) and cattle (Symonds et al. 1981; Wilton et al. 1988 ) the additional urea-N released by the liver exceeded the additional NH 3 removed by more than two-fold. Thus, in the short term, stimulation of glutamate production from NH 3 and oxo-glutarate through glutamate dehydrogenase appeared to be limited, and additional aspartate-N from catabolic deamination of AAs was needed to balance NH 3 flow through the carbamoyl-phosphate synthase 1ornithine transcarbamylase route.
The current observations challenge this view. Although the maximum hepatic capacity for NH 3 removal was exceeded by over 650 mmol/min during the NH 4 HCO 3 infusion, with hyperammonaemia established within 10 min, there was no apparent need for additional AA-N inputs to maintain NH 3 -stimulated ureagenesis. Moreover, rather than the over-production of urea-N relative to NH 3 extraction reported by others, here the average underconversion of 222 mmol N/min to urea ðP ¼ 0 : 004Þ and the reduction in lysine removal (25 : 1 mmol/min, P ¼ 0 : 02) provide support for the concept that shortterm inhibition of AA oxidation may occur during NH 3 overload. Interestingly, this is contrary to the proposal that NH 3 detoxification leads to elevated catabolism of AAs (Reynolds, 1992; Parker et al. 1995) . The reduction in non-NH 3 urea-N release by the liver could also indicate that the unaccounted N may be used for synthesis of AAs. Studies in vitro and in vivo have shown that rapid and substantial transfer of 15 N from 15 NH 4 1 to AAs can occur within the liver (Geissler et al. 1992; Luo et al. 1995) . In addition, incubation of hepatocytes or liver perfusion with NH 4 Cl resulted in intracellular accumulation of citrulline, aspartate, glutamate, glycine, serine and alanine (Demigne et al. 1991; Nissim et al. 1992) or increased release of glutamate, citrulline and alanine (Nissim et al. 1992; Luo et al. 1995; Brosnan et al. 1996) . The elevated net release of glutamate and lowered net removal of citrulline across the liver in the current study provide confirmatory evidence in vivo of the potential importance of these mechanisms in reponse to acute NH 3 administration.
Care was taken in the present study to avoid stimulation of AA catabolism associated with acidosis, as encountered with use of NH 4 Cl (Reaich et al. 1992; Lobley et al. 1995) ; this precaution may account for the differences observed between the current study and earlier studies conducted by Barej et al. (1987) and Orzechowsky et al. (1988) .
Time course events
The stability of hepatic NH 3 utilisation together with the progressive increase in urea-N synthesis observed during maximal stimulation with NH 3 have two important consequences. First, the convergence of incremental NH 3 removal and urea-N release towards the end of the infusion minimised the apparent reduction in non-NH 3 urea-N release, suggesting that any conservation of AAs is only a transient response. Second, any factors that initially limited N flux through the ornithine cycle must have been subjected to short-term control.
The activity of carbamoyl-phosphate synthase 1, the rate-limiting enzyme of the cycle and known to be insensitive to product inhibition by carbamoyl phosphate (Meijer et al. 1990 ), was probably not altered, because that would have increased hepatic NH 3 removal over the infusion period. Under the experimental conditions created by the infusion (i.e. steady NH 3 removal and increase in average hepatic glutamate release), however, stimulation of carbamoyl-phosphate synthase 1 activity may have occurred through a progressive transfer of NH 3 -N from glutamate to carbamoyl phosphate synthesis.
Ornithine availability has been shown to limit rates of urea synthesis in isolated hepatocytes (Lund & Wiggins, 1986) . In the present experiment, the marked shift from release to uptake recorded for hepatic ornithine transfers (7 : 1 v. 25 : 4 mmol/min, P , 0 : 001), and the depletion of ornithine plasma concentrations ðP , 0 : 05Þ indicate that the liver demand for this metabolite increased substantially during NH 4 HCO 3 infusion. Whether hepatic ornithine concentration rose in parallel to these transfers is unclear, as there was also reduced net uptake of two products, citrulline and arginine.
Amino acid metabolism
Time course analysis highlighted the importance of hepatic NH 3 removal for maintaining NH 3 homeostasis in ruminant animals. The two major mechanisms for NH 3 detoxication, ureagenesis and glutamine synthesis, are highly compartmentalised in the liver acinus, the ornithine cycle enzymes being expressed in periportal hepatocytes and glutamine synthetase in perivenous cells (Haussinger et al. 1992; Rossouw et al. 1999) . Thus, any overflow of NH 3 that escapes periportal ureagenesis stimulates perivenous glutamine synthesis. In the current study, however, although ureagenic capacity was exceeded, the liver remained a net consumer (albeit at a lesser rate) of glutamine during NH 3 overload. Nonetheless, plasma concentrations of glutamine were substantially increased during NH 3 infusion, suggesting that glutamine synthesis may be stimulated in other tissues. Indeed, Leweling et al. (1996) reported an increase in plasma and muscle glutamine concentrations during hyperammonaemia in rats. This was accompanied by a decline in glutamate, alanine and branched-chain AA concentrations in both compartments. The authors hypothesised that enhanced branched-chain AA degradation occurred to restore the intramuscular glutamate pools, depleted during the synthesis of glutamine induced by hyperammonaemia. Although arterial plasma alanine and glutamate concentrations tended to decrease during the infusion of NH 4 HCO 3 in the current study, there were no changes in arterial branched-chain AA concentrations. Instead, branched-chain AA utilisation by the PDV was enhanced, suggesting mechanisms in addition to muscle degradation of branched-chain AA to provide glutamate C or N may contribute to lower arterial branched-chain AA concentrations during hepatic NH 3 overload.
Concluding remarks
The results of this experiment indicate that it is unlikely that, in the short term, maximal rates of liver NH 3 removal will stimulate AA utilisation to balance NH 3 incorporation to urea synthesis. Moreover, maximal rates of NH 3 removal were reached at least 20 min earlier than approximately equivalent rates of urea synthesis, with a significant increase in hepatic removal of ornithine and decrease in plasma ornithine concentration. Thus, in sheep, short-term adaptation of hepatic urea synthesis to NH 3 overload in vivo might be controlled by ornithine availability to liver cells. NH 3 supply in excess to liver removal resulted in higher arterial concentrations of NH 3 and glutamine but did not alter glutamine release by the liver. Instead, hepatic release of glutamate increased and there was a marked reduction in liver removal of lysine and splanchnic release of tyrosine and branched-chain AA.
